CSTL Q2 2020 Earnings — Castle Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CSTLCastle Biosciences, Inc.

$772M

Q2 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$13M+18.4% YoY

Gross Profit

$11M83.1% margin

Operating Income

-$645,000-5.1% margin

Net Income

-$1M-10.8% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

-27.0%

Cash Flow

Operating Cash Flow

$14M

Free Cash Flow

$12M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$202M

Total Liabilities

$44M

Stockholders' Equity

$158M

Cash & Equivalents

$180M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$11M	+18.4%
Gross Profit	$11M	$9M	+20.8%
Operating Income	-$645,000	$607,621	-206.2%
Net Income	-$1M	-$1M	-8.4%